Targeting of innate immune response to tumor site

Details for Australian Patent Application No. 2009207287 (hide)

Owner Hadasit Medical Research Services and Development Gavish-Galilee Bio Applications Ltd

Inventors Shahar, Ehud; Pitcovski, Jacob; Gorodetsky, Raphael

Agent FB Rice

Pub. Number AU-A-2009207287

PCT Pub. Number WO2009/093250

Priority 61/006,659 25.01.08 US

Filing date 25 January 2009

Wipo publication date 30 July 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/093250 Priority application(s): WO2009/093250

2 August 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Gavish-Galilee Bio Applications Ltd; Hadasit Medical Research Services and Development, Application No. 2009207287, under INID (71) correct the co-applicant to Hadasit Medical Research Services and Development Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207291-Methods and compositions for diagnosing complications of pregnancy

2009207280-System for generating a customized financial trade article